Search Results - "García‐Mateo, A."

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC) by Sanoja-Flores, L., Flores-Montero, J., Garcés, J. J., Paiva, B., Puig, N., García-Mateo, A., García-Sánchez, O., Corral-Mateos, A., Burgos, L., Blanco, E., Hernández-Martín, J., Pontes, R., Díez-Campelo, M., Millacoy, P., Rodríguez-Otero, P., Prosper, F., Merino, J., Vidriales, M. B., García-Sanz, R., Romero, A., Palomera, L., Ríos-Tamayo, R., Pérez-Andrés, M., Blanco, J. F., González, M., van Dongen, J. J. M., Durie, B., Mateos, M. V., San-Miguel, J., Orfao, A.

“…Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients…”
Get full text

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma by Flores-Montero, J, Sanoja-Flores, L, Paiva, B, Puig, N, García-Sánchez, O, Böttcher, S, van der Velden, V H J, Pérez-Morán, J-J, Vidriales, M-B, García-Sanz, R, Jimenez, C, González, M, Martínez-López, J, Corral-Mateos, A, Grigore, G-E, Fluxá, R, Pontes, R, Caetano, J, Sedek, L, del Cañizo, M-C, Bladé, J, Lahuerta, J-J, Aguilar, C, Bárez, A, García-Mateo, A, Labrador, J, Leoz, P, Aguilera-Sanz, C, San-Miguel, J, Mateos, M-V, Durie, B, van Dongen, J J M, Orfao, A

“…Flow cytometry has become a highly valuable method to monitor minimal residual disease (MRD) and evaluate the depth of complete response (CR) in bone marrow…”
Get full text

S871 CURATIVE STRATEGY (GEM‐CESAR) FOR HIGH‐RISK SMOLDERING MYELOMA: CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (KRD) AS INDUCTION FOLLOWED BY HDT‐ASCT, CONSOLIDATION WITH KRD AND MAINTENANCE WITH RD by Mateos, M.‐V., Martínez‐López, J., Rodríguez‐Otero, P., González de la Calle, V., González, M.‐S., Oriol, A., Gutiérrez, N.‐C., Paiva, B., Rios, R., Rosiñol, L., Alvarez, M.‐A., Calasanz, M.‐J., Bargay, J., González, A.‐P., Alegre, A., Escalante, F., Martínez, R., Puig, N., Rubia, J., Teruel, A.‐I., Cedena, M.‐T., Arriba, F., Palomera, L., Hernández, M.‐T., López, J., Martín, J., García‐Mateo, A., Ocio, E., Bladé, J., Lahuerta, J.‐J., San Miguel, J.

“…Background: SMM is an asymptomatic and heterogeneous plasma cell disorder. Both Spanish Myeloma and ECOG Groups have demonstrated that pts at high risk of…”
Get full text

Sobre un método comúnmente utilizado para la puntuación de tests en la evaluación del rendimiento educativo by Miguel A. Mateo García

“…This paper tries to be a reflection on using test formula scoring for the assessment of educational achievement. To start, basic ideas about tests and putative…”
Get full text

PB0212 Patient with Spontaneous and Severe Bleeding Episodes Diagnosed of Vascular Ehlers-Danlos Syndrome with a De Novo Pathogenic Variant by Marcellini-Antonio, S., Corrales-Insa, I., Bandini, P., Borrás, N., Martin-fernández, L., Galán-Álvarez, P., torres-Tienza, A., Vidal- Pérez, F., Valencia-Castillo, S., García-Mateo, A., Olivier-Cornacchia, C., Queizán-Hernández, J.

Get full text

Implementation of third-generation digital PCR for non-invasive prenatal diagnosis of sickle cell disease and early detection by Ferrer Benito, S., Gómez Álvarez, M., Torrejón Martínez, M.J., López Rubio, M., del Orbe Barreto, R.A., Arbeteta Juanis, J., Muruzabal Siges, M.J., Salido Fiérrez, E.J., García Mateo, A., Recasens, V., Martínez Nieto, J., Villegas Martínez, A.M., González Fernández, F.A., Ortega Montero, A.B., García Moreno, L., Ramiro León, S., Ropero Gradilla, P., Benavente Cuesta, C.

“…Sickle Cell Disease (SCD) is one of the most prevalent autosomal recessive disease, affecting over 600,000 newborns globally each year. In Spain, the Spanish…”
Get full text

PS1398 RECOVERY OF POLICLONAL IMMUNOGLOBULINS AS A PREDICTOR FACTOR OF INCREASED PROGRESSION‐FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA INELIGIBLE FOR ASCT by Dávila, J., González‐Calle, V., Puig, N., Bárez, A., Escalante, F., López, R., Alonso, J.M., Aguilar, C., García‐Mateo, A., Contreras, T., Labrador, J., Aguilera, C., Coca, A. García, Hernández, R., Mateos, M.V., Ocio, E.M.

“…Background: Immunoparesis is the suppression of polyclonal immunoglobulins and is present in about 85% of patients diagnosed of multiple myeloma (MM). Our…”
Get full text

PF555 PROGNOSTIC VALUE OF NEXT GENERATION FLOW MONITORING CIRCULATING TUMOR PLASMA CELLS IN PERIPHERAL BLOOD ON MYELOMA PATIENTS AFTER TREATMENT by Flores, L. Sanoja, Montero, J. Flores, Contreras‐Sanfeliciano, T., Puig, N., Mateos, A. Corral, Sánchez, O. García, Campelo, M. Díez, Pontes, R., Martín, L. García, Alonso, J.M. Alonso, Mateo, A. García, Franco, C. Aguilar, Labrador, J., García, A. Báez, González, M., Mateos, M.V., Durie, B., Van Dongen, J., Orfao, A.

“…Background: After the introduction of novel and more‐effective therapies in multiple myeloma (MM) the number of patients achieving high quality responses has…”
Get full text

PS1352 DISSECTING THE BONE MARROW IMMUNE MICROENVIRONMENT IN THE COMPLETE SPECTRUM OF MONOCLONAL GAMMOPATHIES: POTENTIAL IMPLICATIONS IN DISEASE PATHOGENESIS by Puig, N., Paíno, T., Pérez, J.J., Rodero, E., Paiva, B., Cedena, M.‐T., Díaz‐Tejedor, A., Aires‐Mejía, I., Contreras, T., Pessoa, R., Garayoa, M., García‐Sanz, R., Gutiérrez, N., Calle, V. González, Oriol, A., Rosiñol, L., Bargay, J., Escalante, F., Rubia, J., Arriba, F., Hernández, M.‐T., Mateo, A. García, Bladé, J., Lahuerta, J.J., Miguel, J. San, Mateos, M.‐V., Ocio, E.M.

“…Background: The bone marrow microenvironment (BMME) is crucial for the development and persistence of multiple myeloma (MM). This specific BMME includes immune…”
Get full text

PF609 HEAVY&LIGHT CHAIN MONITORING IN HIGH RISK SMOLDERING MULTIPLE MYELOMA PATIENTS INCLUDED IN THE GEM‐CESAR TRIAL: COMPARISON WITH CONVENTIONAL AND MINIMAL RESIDUAL DISEASE IMWG RESPONSE ASSESSMENT by Puig, N., Contreras, T., Paiva, B., Cedena, M.‐T., Pérez, J.J., Aires, I., Agullo, C., Martínez‐López, J., Rodríguez‐Otero, P., González de la Calle, V., González, M.‐S., Oriol, A., Gutiérrez, N.‐C., Rios, R., Rosiñol, L., Alvarez, M.A., Calasanz, M.J., Bargay, J., González, A.P., Alegre, A., Escalante, F., Martínez, R., Rubia, J., Teruel, A.I., Arriba, F., Palomera, L., Hernández, M.T., López, J., Martín, J., Mateo, A. García, Ocio, E.M., Bladé, J., Lahuerta, J.J., Miguel, J. San, Mateos, M.V.

“…Background: The GEM‐CESAR trial is a potentially curative strategy for high‐risk smoldering multiple myeloma (HRsMM) patients (pts) in which the primary…”
Get full text

DIMENSIONES DE LA CALIDAD DE LA ENSEÑANZA UNIVERSITARIA by MATEO GARCÍA, Miguel A, Juan FERNANDEZ SANCHEZ

“…El presente trabajo trata de mostrar los fundamentos empíricos de un especial desglose dimensional que se opera sobre el CEPUC (Cuestionario de Evaluación del…”
Get full text